精品国产乱码一区二区,男女啪啪啪免费网站,欧美人与禽ZoZ0性3D,国产精品无码久久久久不卡
<li id="wc4go"><tbody id="wc4go"><em id="wc4go"></em></tbody></li>
<li id="wc4go"></li>
<rt id="wc4go"><delect id="wc4go"></delect></rt>
<li id="wc4go"></li>
Home
About
About Us
Team
Contact
News
Science
Our Science
Pipeline
Clinical trials
Expanded access policy
Career
Work in highlightll pharma
Join Us
中文
中文
|
中文
Home
About
News
Science
About
About Us
Team
Contact
Hangzhou Highlightll News
We strive to discover breakthrough medicines which would have high impact on health care
The current position：
Home
/
News
/
Company news
Return
Highlightll Pharmaceutical TLL-018 Achieved Breakthrough Results in a Phase II Trial for Rheumatoid Arthritis
January 29,2023 From:
Highlightll Pharmaceutical
Prev
Selective JAK1/TYK2 Inhibition: A Novel Way to Overcome Tofacitinib Resistance in RA?
Next
Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018- 205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
Return List
About
About Us
Team
Contact
News
Company news
Career
Work in highlightll pharma
Join Us
Contact
Add
RM 301/302, BLDG 4, Qiantang District, Hangzhou 310018, China
Tel
+86-0571-88881586
Email
info@highlightpharma.com
Copyright ? 2021-2022 HIGHLIGHTLL PHARMA All Rights Reserved
浙ICP備2021020990號-1
Power By：
Baling
